| Name | Title | Contact Details |
|---|
Medlink Imaging is a Teterboro, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Astute Medical is committed to improving patient outcomes through the identification and validation of unique biomarkers. Our measurement methods help rapidly assess high-risk acute conditions and diseases. By incoporating useful clinical tools, we help healthcare professionals provide rapid, accurate and life-saving responses.
Advanced Reimbursement Management offers a suite of services encompassing Medicaid reimbursement. These service lines include: Medicaid Eligibility Assistance Services – ARM provides both on-site team members to assist with I/P and O/P enrollment of your Self Pay Patients in Medicaid as well as centralized eligibility support team members who do follow up work from our central business office. Accounts Receivables Management – ARM handles a variety of services from initial Medicaid claims billing to follow-up of aged claims at 60,90,120+ days. We use our clinical audit nursing staff to do our own in house reviews when submitting claims for reconsideration. This is an included part of the service at no extra charge. Clinical Auditing Services – ARM provides a variety of clinical auditing services in addition to claims review as part of A/R management. This includes RACs, Defense Audits (all payers), Stop Loss / Carve Out, Charge Hold / Lost Charge. In all situations, ARM provides trending feedback to the hospital in an effort to provide long term solutions. ARM can do both hourly pricing or contingency rate pricing, depending on your preference. Post Payment Review (Zero Balance) – ARM can review all of your Medicaid claims for variance from expected reimbursement amounts, and provide detailed trending, The best part is that we are budget positive because this is truly “found money”
TransMedics Inc. is the world`s leader in portable ex-vivo perfusion and assessment of donor organs for transplantation. The company was founded to address the need for more and better organs for transplantation, and is focused on transforming the standard of care – increasing organ utilization, improving patient outcomes, and reducing transplant costs throughout the heath care system. The OCS Lung, OCS Heart and OCS Liver are all CE marked and FDA approved devices.
Median Technologies provides innovative imaging solutions and services to advance healthcare for everyone. As The Imaging Phenomics Company®, Median provides insights into novel therapies and treatment strategies. Our unique solutions, MediScan® for lesion management in patient care, Lesion Management Solution (LMS) for lesion detection, measurement and reporting in clinical trials, and our imaging phenotyping system iBiopsy®, together with our global team of experts, are advancing the development of new drugs and diagnostic tools to monitor disease and assess response to therapy. Median Technologies supports biopharmaceutical sponsors and healthcare professionals around the world in bringing new and targeted treatments to patients in need with an eye on reducing overall costs. This is how we are helping to create a healthier world. Founded in 2002, based in Sophia-Antipolis, France, with a US subsidiary in Boston, Median has received the label “Innovative company” by the BPI and is listed on Euronext Paris` Alternext market (ISIN: FR0011049824, ticker: ALMDT). The company is eligible for the PEA-PME SME equity savings plan setup and has received the label Pass French Tech Promotion 2016-2017.